Webinar

How Regulatory Information Management Systems can support Life Sciences

20 January 2021 | Online

Catch the latest updates on regulatory responsiveness since Covid-19 has triggered an unprecedented disruption to global life sciences and public health sectors.

Covid-19 has triggered unprecedented disruption to global life sciences and public health, exposing some gaping holes in drug companies’ product insights and regulatory responsiveness. In this webinar, David Gwyn will explore some of the lessons learnt in 2020 to assess how companies might transform their regulatory operations in 2021, to improve their adaptability and become better equipped for continued uncertainty.


He will demonstrate how pharmaceutical companies must get their global operations in order and render their regulatory information more tightly interwoven. Whatever organizations’ immediate agenda, an effective plan for 2021 in relation to RIM transformation must be put in place.

Why attend?

In this webinar, you'll learn about:

  • Long-term remote working/team fragmentation
  • The relative ease of managing regulatory processes across distance when all contributing systems are tightly welded together in a unified manner
  • The scope for leveraging a unified RIM solution to accelerate the drug development process and scope for maintaining production during periods of disruption.

Meet the Speakers

David Gwyn

Vice President for Life Sciences, Amplexor

With more than 25 years of experience in the Life Sciences industry, David Gwyn is a seasoned executive with extensive experience. As a Vice President for Amplexor Life Sciences, David’s main focus is aligning customer needs with the capabilities of the company’s Life Sciences Suite to ensure that the solution meets the needs of the customer.

REGISTRATION

How Regulatory Information Management Systems can support Life Sciences

20 January | 2:00 - 3:00 PM GMT

Fill out the form to register